AVERAGE VOLUME
5-Day
10-Day
30-Day
Aurobindo Pharma Ltd.
- NSE
- BSE
410.25
14.45 (3.65%)
15:59 | 15-11-2019
Volume
8,952,221
Mkt Cap (₹ Cr.)P/E (x)
Aurobindo Pharma Ltd.
ET 500
Rank 2018
91
ENGNew
- ENG - English
- HIN - हिन्दी
- GUJ - ગુજરાતી
- MAR - मराठी
- BEN - বাংলা
- KAN - ಕನ್ನಡ
- ORI - ଓଡିଆ
- TEL - తెలుగు
- TAM - தமிழ்
- NSE15:59 | 15-11-2019
- BSE16:01 | 15-11-2019
410.25
Today's Change
14.45 (3.65%)
Volume
8,952,221
Open
402.00
Prev. Close
395.80
Day's Trend
- Bid
- Mkt Cap (₹ Cr.)
- P/E (x)
- P/B (x)
- Div_ Yield (%)
- BETABETA1 Month3-Months6-Months1 Year3-Years
- Offer
- Face Value (₹)1.00
- EPS-TTM (Rs.)43.91
- BV/share (₹)237.11
- 52Wk L/H389.35/ 838.00
- Avg. Daily Volatility %Avg. Daily Volatility %1 Month3-Months6-Months1 Year3-Years
InsightsEvents|
Recos|
Updates|
News|
Speed
Aurobindo Pharma Ltd Stock Price F & O Quotes
Buy
Buy
Sell
Sell
Buy
Buy
Buy
Sell
Buy
Buy
Buy
Sell
Buy
Sell
Buy
Buy
Buy
Buy
Buy
Buy
Aurobindo Pharma Ltd.Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation| Announcement
14 Nov,2019, 06:02PM IST
Share market update: Nifty Pharma index down; Aurobindo Pharma slumps 8%| News
14 Nov 2019, 10:12AM IST
Share market update: Aurobindo Pharma, Vodafone Idea among top losers on BSE| News
14 Nov 2019, 09:21AM IST
Aurobindo Pharma Ltd.Sub: Completion Of USFDA Inspection At Our Unit IV - Reg.,| Announcement
13 Nov,2019, 09:39PM IST
Aurobindo Pharma Ltd.UNAUDITED FINANCIAL RESULTS FOR THE QUARTER AND HALF YEAR ENDED 30TH SEPTEMBER 2019| Announcement
12 Nov,2019, 06:04PM IST
Dalal Street week ahead: Macro data, key earnings among the top market movers| News
10 Nov 2019, 09:56AM IST
Aurobindo Pharma Ltd.Clarification On News Article AurobindoS Buyout Of Sandoz Assets Delayed On FTC Query Appeared In ET On November 7, 2019...| Announcement
08 Nov,2019, 11:34AM IST
Share market update: Nifty Pharma index down; Glenmark Pharma slips 4%| News
07 Nov 2019, 10:14AM IST
After Market: PCJ shines, Titan tanks, Aurobindo swallows a bitter pill; 37 stocks 'overbought'| News
06 Nov 2019, 05:21PM IST
Aurobindo Pharma Ltd.Clarification On News Article Aurobindo Pharma Under USFDA Scrutiny - Reg.,| Announcement
06 Nov,2019, 09:45AM IST
Aurobindo Pharma Ltd.Clarification sought from Aurobindo Pharma Ltd| Announcement
05 Nov,2019, 05:21PM IST
Aurobindo Pharma Ltd.Board to consider Q2 results & Interim Dividend on Nov 12, 2019| Announcement
31 Oct,2019, 12:28PM IST
Aurobindo Pharma Ltd.Board Meeting Intimation for Board Meeting To Consider The Unaudited Financial Results Of The Company For The Second Qua...| Announcement
31 Oct,2019, 11:26AM IST
Aurobindo Pharma Ltd.Announcement under Regulation 30 (LODR)-Newspaper Publication| Announcement
29 Oct,2019, 02:36PM IST
Aurobindo Pharma Ltd.Announcement under Regulation 30 (LODR)-Meeting Updates| Announcement
28 Oct,2019, 01:32PM IST
Aurobindo Pharma Ltd.Announcement under Regulation 30 (LODR)-Newspaper Publication| Announcement
28 Oct,2019, 01:07PM IST
Aurobindo Pharma Ltd.Announcement under Regulation 30 (LODR)-Newspaper Publication| Announcement
26 Oct,2019, 05:25PM IST
Aurobindo Pharma Ltd.Notice Of The Meeting Of The Equity Shareholders Of Aurobindo Pharma Limited To Be Convened Pursuant To The Directions O...| Announcement
25 Oct,2019, 12:41PM IST
Aurobindo Pharma Ltd.Announcement under Regulation 30 (LODR)-Press Release / Media Release| Announcement
24 Oct,2019, 11:06AM IST
Aurobindo Pharma Ltd.Shareholding for the Period Ended September 30, 2019| Announcement
17 Oct,2019, 03:44PM IST
Aurobindo Pharma Ltd. share price
up by 3.65% from its previous close of Rs 395.80. Aurobindo Pharma Ltd. stock last traded price is 410.25
Aurobindo Pharma Ltd. Share Price
Value
Today/Current/Last
410.25
Previous Day
395.80
Aurobindo Pharma Ltd. Quarterly Results
Yesconsolidate
Loading...Sep 2019
% Chg (Quarterly)
% Chg (Yearly)
Peer Range
Trend
Last 12 Quarters Trend
Sales
5,518.27
3.01
18.24
0.00
8123.35
Other Operating Income
82.20
-6.34
-2.47
0.00
174.16
Operating Profit
1,140.22
-0.54
15.61
-62.92
2640.87
Other Income
20.62
30.67
-21.48
-0.20
200.85
EBITDA
1,160.84
-0.12
14.65
-62.92
2640.87
Interest
40.94
-17.94
15.68
0.00
116.00
Depreciation
243.31
1.02
48.65
0.00
473.28
Tax
224.37
-1.49
27.90
-320.70
266.03
Net Profit
639.86
0.66
4.65
-127.07
1106.80
EPS (₹)
10.92
0.65
4.60
-12.25
66.68
View Detailed FinancialsProfit and LossCash FlowsBalance SheetQuarterly ResultsHalf Year resultsCapital Structure
Aurobindo Pharma Ltd ResutlsAurobindo Pharma Q1 ResultsAurobindo Pharma Q2 ResultsAurobindo Pharma Q3 ResultsAurobindo Pharma Q4 Results
Aurobindo Pharma Ltd Share Price
Companies
LTP
Intraday
1W %
1M %
1 QTR %
1 YR %
3 YR %
5 Yr %
Trend -
D|M|Y
Top Loser for the period amongst the peers
Top Gainer for the period amongst the peers
Aurobindo Pharma Ltd Risk Return Comparison
with peersNewAurobindo Pharma Ltd Financial Comparison
with peersManagement Efficiency
Aurobindo Pharma Ltd
peer Average
Peer Range
Trend
Return on Equity (%)
17.02
8.87
-99.01
47.57
Return on Assets (%)
9.06
5.79
-27.48
26.25
Return on capital Employed (%)
10.35
6.57
-130.86
23.01
Fixed Assets Turnover (x)
1.06
0.97
0.00
2.79
Profitability and Growth
Gross Profit Margin (%)
16.78
-8.77
-980.00
34.42
Operating Profit Margin(%)
20.20
0.38
-896.19
37.94
Net Profit margin (%)
12.08
2.06
-461.80
94.28
Financial Strength
Liquidity
Quick Ratio (x)
1.47
1.65
0.08
9.50
Current Ratio (x)
2.75
2.40
0.21
9.50
Cash ratio (x)
0.34
0.22
-0.52
1.40
Solvency
Debt Equity Ratio (x)
0.01
0.27
0.00
1.77
Coverage Ratios
Cash flows to long term debt (x)
2.17
3.76
0.00
45.52
Better performer than its peers on this ratioAverage performer than its peers on this ratioUnderperformer than its peers on this ratio
Aurobindo Pharma Ltd Share Holding as on 30-09-2019
| Category | No. of shares | Percentage |
|---|---|---|
| Promoters | 285,925,934 | 48.80 |
| ForeignInstitutions | 128,642,426 | 21.95 |
| NBanksMutualFunds | 74,172,806 | 12.66 |
| GeneralPublic | 50,169,216 | 8.56 |
| Others | 27,073,648 | 4.62 |
| ForeignPromoter | 18,000,000 | 3.07 |
| FinancialInstitutions | 1,954,579 | 0.33 |
MF Ownership Of Aurobindo Pharma Ltd. Shares
Fund Name
Category
No. of shares
% Change in Shares (MOM basis)
% of AUM
Amount Invested (in ₹ Cr)
HDFC Balanced Advantage Direct-GPortfolio as on 31-10-2019
Hybrid: Dynamic Asset Allocation
8570828
0.00%
0.91%
402.70
HDFC Hybrid Equity Direct-GPortfolio as on 31-10-2019
Hybrid: Aggressive Hybrid
7361000
0.00%
1.64%
345.86
Equity: Large Cap
1862297
89.85%
0.55%
87.50
Liquid, Ultra Short Term funds and FMPs are not taken into account.
More SchemesAbout Aurobindo Pharma Ltd.
Aurobindo Pharma Ltd., incorporated in the year 1986, is a Large Cap company (having a market cap of Rs 24026.41 Crore) operating in Pharmaceuticals sector.
Aurobindo Pharma Ltd. key Products/Revenue Segments include Pharmaceuticals which contributed Rs 11922.63 Crore to Sales Value (97.26 % of Total Sales), Export Incentives which contributed Rs 303.72 Crore to Sales Value (2.47 % of Total Sales), Sale of services which contributed Rs 16.07 Crore to Sales Value (0.13 % of Total Sales) and Scrap which contributed Rs 15.47 Crore to Sales Value (0.12 % of Total Sales)for the year ending 31-Mar-2019.
For the quarter ended 30-09-2019, the company has reported a Consolidated sales of Rs 5518.27 Crore, up 3.01 % from last quarter Sales of Rs 5356.84 Crore and up 18.24 % from last year same quarter Sales of Rs 4667.12 Crore Company has reported net profit after tax of Rs 639.46 Crore in latest quarter.
The company’s top management includes Dr.M Sivakumaran, Dr.(Mrs.)Avnit Bimal Singh, Mr.K Nithyananda Reddy, Mr.K Ragunathan, Mr.M Madan Mohan Reddy, Mr.M Sitarama Murthy, Mr.N Govindarajan, Mr.P Sarath Chandra Reddy, Mr.P V Ramprasad Reddy, Mrs.Savita Mahajan. Company has BSR & Associates LLP as its auditoRs As on 30-09-2019, the company has a total of 585,938,609 shares outstanding.
View DetailsChairman's SpeechCompany HistoryDirectors ReportBackground informationCompany ManagementListing InformationFinished ProductsBoard MeetingsAGM/EGM
Close X
WatchlistPortfolio
Current Price>: 2389.88
Set Alert
Loadingdata